COMETRIQ
These highlights do not include all the information needed to use COMETRIQ safely and effectively. See full prescribing information for COMETRIQ. COMETRIQ (cabozantinib) capsules, for oral useInitial U.S. Approval: 2012
1a0c3bea-c87b-4d25-bb44-5f0174da6b34
HUMAN PRESCRIPTION DRUG LABEL
Aug 23, 2023
Exelixis, Inc.
DUNS: 785991949
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
cabozantinib
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
cabozantinib
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
cabozantinib
Product Details
FDA regulatory identification and product classification information